Disease Segment Dominates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dementia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
The global dementia drugs market was valued at approximately USD 12,736. 06 million in 2020 and is expected to witness a revenue of USD 19,655. 10 million in 2026, with a CAGR of 7. 87% over the forecast period.
April 15, 2021 08:24 ET
| Source:
ReportLinker
ReportLinker
Lyon, FRANCE
New York, April 15, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Dementia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - https://www.reportlinker.com/p06062856/?utm source=GNW
The outbreak of the COVID-19 pandemic is expected to have a significant impact on the Dementia drugs market. According to a research study by Katya Numbers et al., published in Nature Reviews Neurology, in January 2021, the population with dementia are at high risk of contracting COVID- ....

New York , United States , United Kingdom , Eli Lilly , National Institute Of Health , World Health Organization , National Institute On , Office For National Statistics United Kingdom , Drug Administration , National Clinical Trials , Alzheimer Disease International , Germany Federal Statistical Office , Alzheimer Association , Translational Research , Drugs Market , Katya Numbers , Nature Reviews Neurology , National Statistics United Kingdom , Dementia Drugs , Disease International , National Institute , Disease Related Dementias , Disease Segment Dominates , Same Over , Disease Facts , Mild Cognitive Impairment ,